Even though the recommended dose is lower in the PM population, the AUC is approximately twice that of the UM and EM populations, which is in stark contrast to the clearance value, where an increasing trend was seen in the UM and EM populations ( Figure 12 ).
← all excerpts
Optimising Fluvoxamine Maternal/Fetal Exposure during Gestation: A Pharmacokinetic Virtual Clinical Trials Study.
1
—
—